March 2, 2022
Lost in the wilderness
There are certain fundamental truths when it comes to our wacky world. One is pharmaceutical companies have no business getting into MedTech or digital/virtual. Yesterday we wrote about the posterchild for screwing up Sanofi. Yep, instead of getting out of diabetes and selling the franchise when it has value, they invest $30 million in Dario. Honestly, I truly wish Dexcom would make them an offer they can’t refuse and be done with it but then again Sanofi just doesn’t have the capacity to recognize a good deal.
Sanofi isn’t the only company in pharma who has . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
